TSANZ home

Results for "hayley See"

Home 5 Search query for: hayley See
Results for "hayley See"
VOLUME 7.06 – JULY 2022

VOLUME 7.06 – JULY 2022

Research Roundup:

July 2022

Welcome Message

Welcome to another issue of Research Roundup. Best of luck to everyone who applied for the recent Medical Research Future Fund grants. I hope you have all caught up on some sleep by now!

Speaking of grants there is a whole host of opportunities listed in this newsletter and quite a few are closing soon. TSANZ has two travel grants closing at the start of August, one for the inaugural TSANZSRS Education Hub, and one for the TSANZSRS NZ Branch ASM. Speaking of the NZ Branch ASM, their new investigator award closes on the 14th of August. Outside of TSANZ Cure4CF’s Holckner Family CF Impact Grant is offering up to $500,000 for Cystic Fibrosis research and this grant closes on the 5th of August. For those working outside of research ELF has grants of up to €1,000 for not-for-profit organisations, patient groups and healthcare professionals closing very soon, on the 31st of July.

In addition, the TSANZSRS ASM abstract linked awards have just opened! Details for these awards are outlined below. In related and exciting news, the value of both the Ann Woolcock New Investigator Award and Janet Elder International Travel Awards have increased to $5k each. A lot of the abstract linked awards are targeted to early-mid career researchers. If you fit into this category and have been thinking about submitting an abstract to TSANZ, you should absolutely consider extending your application to go for one, or even both of these awards at the same time. It may just be the steppingstone that takes you that little bit further along your career path.

The Limbic, Respirology and Respiratory Research Review have some excellent reads, and if you’re after further educational opportunities there are some interesting webinars across the next week. RACP are running a COVID webinar series in July, there’s one more session you can catch on the 28th; “COVID-19: Where to now?”. Next month on the 3rd of August ACTnet running a seminar on TB genomics.

Finally, if you ever find yourself feeling a little deprived of motivation, I strongly suggest a google search for Admiral McRaven’s 2014 commencement speech. He outlines 10 life lessons from his time as a navy seal…no wait, don’t stop reading yet. Seriously. I now have each of these printed on 10 A4 pieces of paper on the wall in my office. He has been and continues to be a source of inspiration for me, and for those of you who may be looking for that little push to open your next grant application template, this may be the productive procrastination activity for you.

As always, happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

TSANZSRS NZ Branch Meeting 2022 New Investigator Award – Abstract Submissions close 14th August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

TSANZSRS Annual Scientific Meeting 2023

Call for Abstracts

On behalf of the Organising Committees, we warmly invite you to attend the Annual Scientific Meeting of The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand. The TSANZSRS 2023 meeting will be held at Te Pae Christchurch Convention Centre from 25th – 28th March 2023 with opportunities to attend pre-conference Postgraduate Courses on Friday 24th March.

TSANZ abstract awards are now open!

For more information regarding the TSANZSRS 2023 ASM and how to apply for the above awards visit https://www.tsanzsrsasm.com/

 

TSANZ Surveys

Help us improve our educational offerings to members and our skill base by completing the below surveys!

TSANZ Methodology Survey

Evidence-based practice skills among members of the TSANZ

The TSANZ is conducting this voluntary survey to identify members who have specific evidence-based practice (EBP) methodology skills to support the production of position statements and clinical practice guidelines by the Society.

We are asking you to fill out a questionnaire, which should take approximately 15 minutes to complete.

The study gives you an opportunity to tell us about:

  • The skills you have to perform specific elements of a systematic review for the development of Society documents
  • Your interest to learn/improve specific skills or share/teach specific skills

Survey link: https://forms.office.com/r/W6SUisW70g

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Education Hub Logo

Education Hub Travel Grants

The TSANZ and ANZSRS have established a scheme to assist early-career members to attend the TSANZSRS Education Hub. This is to encourage active participation in the Hub and will be awarded to eligible applicants planning to pursue a career in respiratory medicine or related fields.

The travel grant for the 2022 TSANZSRS Education Hub will be to contribute to travel costs to maximum of AU$250*
* based on individual travel requirements with submitted evidence of costs.

Please click here for more information on the travel grant guidelines and eligibility criteria!

Please click here to register for the TSANZSRS Education Hub!

Respirology – Editor’s Choice

Respirology Issue 27.8 August 2022

Inhalational Exposures in Patients with Fibrotic Interstitial Lung Disease: Presentation, Pulmonary Function, and Survival in the Canadian Registry for Pulmonary Fibrosis

Cathryn T. Lee,Mary E. Strek,Ayodeji Adegunsoye,Alyson W. Wong,Deborah Assayag,Gerard Cox,Charlene D. Fell,Jolene H. Fisher,Andrea S. Gershon,Andrew J. Halayko,Nathan Hambly,Nasreen Khalil,Martin Kolb,Stacey D. Lok,Hélène Manganas,Veronica Marcoux,Julie Morisset,Mohsen Sadatsafavi,Shane Shapera,Teresa To,Pearce Wilcox,Christopher J. Ryerson,Kerri A. Johannson

DOI: 10.1111/resp.14267

 

External Grant Opportunities

European Lung Foundation Healthy Lungs for Life Grants

European Lung Foundation (ELF) is offering grants to support Healthy Lungs for Life activities.

Not-for-profit organisations, patient groups and healthcare professionals can apply for a grant of up to €1,000 to support events and activities that meet one or more of the aims of the Healthy Lungs for Life campaign:

Increase knowledge of the impact of poor air quality on lung health and the actions that everyone can take to reduce air pollution and avoid exposure
Highlight the benefits of quitting smoking
Increase knowledge of the importance of physical activity for lung health
Raise awareness of vaccination to prevent lung infections
This year we also strongly welcome applications linked to the topic of climate change and lung health.

Applications are now open for events focused on World Lung Day and awareness days later in 2022. The closing date for applications is 31 July 2022. To find out more and apply please follow this link.

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

Perspectives on Telehealth for the care of patients with Interstitial Lung Disease (ILD)

We are recruiting health professionals who are involved in the care of patients with Interstitial lung disease (ILD) to participate in this research project. Telehealth for ILD provides an opportunity to improve access to healthcare for patients. Its use has rapidly increased during the COVID-19 pandemic, however there is still a high level of dissatisfaction with telehealth amongst both patients with ILD and healthcare professionals. This study will help us to understand the opinions and experiences of patients with ILD, their caregivers and health professionals of using telehealth in the management of ILD, and ways in which the model can be improved.

Participation in the study will involve taking part in one interview, either in person, over the phone or via zoom. If you are interested in participating or would like further information on this study, please contact:
Dr Sheetal Deshpande
Phone: 03 9903 0214
Email: sheetal.deshpande1@monash.edu

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

Climate Change and Health – WA Healthcare Professionals Survey

The University of Western Australia and Department of Health WA are interested in your views on climate change and health. The information gathered through this project will be used to develop public health messaging and resources for both community and health professionals.

All WA healthcare professionals and healthcare workers with direct client or patient care contact are encouraged to participate. The survey is open from 18 July 2022 to 15 August 2022 and can be accessed online at https://consultation.health.wa.gov.au/pahd-sdu/climate-change-and-health/, and will take approximately fifteen minutes to complete.

Queries can be directed to Sarah Joyce at the Western Australia Department of Health, via email at sarah.joyce@health.wa.gov.au, or by phone on (08) 9222 4017.

LFA COVID-19 Survey

Lung Foundation Australia (LFA) are currently running a survey to gain an understanding of how COVID-19 has impacted Australians and what healthcare, information and support may be needed to help people manage ongoing symptoms. If you’ve had COVID-19 or cared for someone who has, LFA would love to hear your experience by completing this 5-10 minute survey. Completing the survey will put you in the running to win a $150 Visa gift card!

Even if you haven’t had COVID-19, you can share your experience on the government response during the pandemic and the impact of the pandemic on your access to healthcare.

Webinars and Seminars

RACP COVID-19

The RACP COVID-19 Expert Reference Group invites you to attend the upcoming July COVID webinar series.

The RACP have hosted a number of COVID-19 webinar series over the past couple of years in order to inform doctors about important COVID-19 matters, discuss key information and share learnings. We have a great line-up of panellists detailed below and are looking forward to some really engaging discussions.

Please register via the link to attend: REGISTRATION LINK

CALL FOR WEBINAR QUESTIONS – 28 JULY

Do you have any burning questions that you would like us to ask at the webinars? Please send them through to COVIDERG@racp.edu.au.

COVID-19: Where to now?

Thursday 28 July, 6pm-7.30pm AEST / 8pm-9.30pm NZST

This webinar will provide attendees with an understanding of some of the lessons learned though the COVID-19 pandemic and how they might be applied moving forward. The webinar will be in the format of an open panel discussion to guided questions as well as Q&A from webinar attendees.

Hosted by:
Dr Susan Graham, rehabilitation physician and Chair of the RACP COVID-19 Expert Reference Group
Associate Professor Asha Bowen, Head, Skin Health Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute and member of the RACP COVID-19 Expert Reference Group

Expert panellists include:
Professor Paul Kelly, Chief Medical Officer, Department of Health
Professor Christopher Blyth, Director, Wesfarmers Centre of Vaccines and Infectious Diseases; Paediatric Infectious Diseases Physician and Clinical Microbiologist
Professor John Massie, Respiratory Physician and Clinical Director, Children’s Bioethics Centre, Royal Children’s Hospital
Dr Paresh Dawda, General Practitioner, Director and Principal Prestantia Health and Next Practice Canberra
Helen Kulas, NSW Respiratory Network Manager
Professor Peter Wark, Senior Staff Specialist – Respiratory and Sleep Medicine, John Hunter Hospital; Co-Chair NSW Respiratory Network

ACTnet TB Genomics Seminar

Whole genome sequencing of Mycobacterium tuberculsosis is increasingly being
implemented for antimicrobial resistance prediction and transmission surveillance. Join us as our expert panellists discuss the application of this technology for TB control.

When: 3rd August 2022
Time: 1200pm-1330pm (AEST)
Register: Here

Speakers

Dr Chris Coulter, QLD MRL – Topic: Introduction TB to Genomics
Dr Chris Coulter is a Microbiologist, the Chair of TB Expert Advisory Group for Tuberculosis in Queensland, and the Director of the Queensland Mycobacterium Reference Laboratory

Dr Norelle Sherry – Topic: Implementation of TB Genomics for Antimicriobial Resistance Prediction and Public Health
Dr Norelle Sherry is an Infectious Diseases Physician & Clinical Microbiologist, co-appointed at MDU-PHL and Austin Health, with a special interest in antimicrobial resistance (AMR). She is also a clinician-researcher, investigating the use of genomics for surveillance of antimicrobial resistance in multiple different settings, and translation of genomics from the research lab into clinical use.

Prof Vitali Sintchenko – Topic: Case Studies in TB Genomics
Professor Vitali Sintchenko is a leading public health microbiologist and informatician who conducts research on biosurveillance of communicable diseases. He is a Fellow of the Royal College of Pathologists of Australasia and the Australian College of Health Informatics. As the Director of CIDM-Public Health (a translational research hub funded by NSW Health), he leads a public health and diagnostic microbiology team working toward improving laboratory and epidemiological. investigations of communicable diseases.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.06 – JULY 2022

VOLUME 7.05 – JUNE 2022

Research Roundup:

June 2022

Welcome Message

Welcome to the June issue of TSANZ Research Round up. First up, I’ve got some questions for you to think about. What do you need to make your funding applications more competitive? Is there a gap in your skills, knowledge base, network, or something else, but you just can’t find a way to fill it? Is there some training that you would really like to get, but can’t find a course or person able to provide it? TSANZ wants to fix these problems for you, but we can’t do that unless you tell us what your needs are.

To do this, please fill out the training needs analysis survey, which should take around 12-minutes and can be accessed here. Big thank you to everyone who has already completed this survey. So that we can provide all our members with the best and most tailored support possible, we need to get at least 300 people to complete this survey, but so far, we have about 100. Thank you to everyone who has already done this. It’s very much appreciated. Would you mind asking anyone and everyone around you to also fill this out? If you like, you could even try and skew the data by having everyone you know request the same training needs, to try and get TSANZ to deliver the support you need first. On that note, Graham, John, Anne, and Hannah, no need to re-read that last sentence or look closer into submissions from my network; Nothing to see here.

While we’re on the topic of training, early bird registration is now open for the inaugural TSANZSRS Education Hub. This is an exciting opportunity for a much needed in-person event, running in Sydney from the 14-15th of October. Yes, you read that right, IN PERSON! There will be a host of workshops to choose from, including sessions to help build skills in crafting successful grant applications and how to get your research published in high quality journals. Of course, one of the biggest benefits of an in-person gathering will be facilitated through the Friday night networking event. Providing an opportunity to reconnect in person with distant colleagues and begin to explore new associations among members with shared interests.

In some other exciting news, a big congratulations to all recipients of Lung Foundation Australia’s Hope Research Fund Grants, and to our members who have been successful with NHMRC Clinical Trials and Cohort Studies Grants. It is fantastic to see this essential respiratory research being supported through competitive grants and awards. Speaking of successes, we would love to help celebrate any of your recent achievements with the broader TSANZ membership by sharing the news in future editions of the research roundup. Instructions on how to do this are provided below.

As usual there are some excellent reads from the Research Review, and Respirology has a special issue focused on occupational lung health. Cure4CF’s Holckner Family CF Impact Grant has just opened, with up to $500,000 is available for Cystic Fibrosis research seeking to develop therapies and cures for the disease. Recruitment is being sought for patients with COPD or ILD for SINFONIA, a singing for breathing trial, and views from healthcare professionals within three different studies. If you have a minute to spare, please help support fellow TSANZ members by contributing to their research.

Finally, some inspirational words to end this edition of research round-up come from anonymous “Not all storms come to disrupt your life, some come to clear your path”.

Happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

Education Hub Logo

TSANZ Education Hub

Registrations are now open for the inaugural TSANZSRS Education Hub on 14-15 October 2022, at Rydges World Square, Sydney.

There will be a wide range of workshops, courses and skills sessions available to choose from, including research skills updates, such as how to craft successful research grant and funding applications, and writing research outcomes for publication.

To view the programme, please visit the Education Hub website.

Of course, there will also be an opportunity to reconnect with colleagues from across Australia and New Zealand at the networking function on the evening of Friday 14th October.

All programme content will be recorded and made available to delegates for 6-months after the Education Hub, giving you access to the entire program, regardless of which sessions you attend at the time.

Register before 4th August 2022 and receive the early bird rate.

We look forward to welcoming you to the TSANZSRS Education Hub in October.

 

Open Request for TSANZ Member Achievements

TSANZ would like to invite members to share their achievements. One of TSANZ Strategic Objectives is to raise the profile of the respiratory research workforce in Australia and New Zealand, especially those who are TSANZ members. As part of this we would like to share member success in our monthly Research Roundup.

Examples of achievements we would like to hear about are:

  • Receipt of major grants, such as grants from the Medical Research Future Fund or the National Health and Medical Research Council
  • Receipt of major honours, such as those from the Order of Australia
  • Notable recent journal publication
  • Completion of a PhD

Please send notification of these achievements to TSANZawards@thoracic.org.au, along with a short blurb (2-3 sentences) about your achievement for us to share. If applicable please include documentation of your achievement, and, if you would like, provide a photo of yourself. Please also share with us success of your fellow TSANZ members!

TSANZ Members awarded the Lung Foundation Australia’s Hope Research Fund 2022 Grant

At the recent Hope Research Fund lunch on 2 June, 13 exceptional researchers from around the country will be awarded $876k in grants, in several different research areas, including asthma, bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and lung cancer. 

Huge congratulations to our talented TSANZ members, 
Lung Foundation Australia – Ludwig Engel Research Grant: Dr. Hayley Scott
Lung Foundation Australia Andrew Harrison Bronchiectasis Fellowship: Prof. Julie Marchant
Lung Foundation Australia John Farrell COPD Fellowship: Dr. Narelle Cox
Lung Foundation Australia – Boehringer Ingelheim Fellowship in COPD: Dr. Arwel Jones
Lung Foundation Australia – Better Breathing Foundation PhD Scholarship in Chronic Lung Disease (full): Mrs. Jessica Walsh
Lung Foundation Australia -Ivan Cash Research Grant: Dr. Sheetal Deshpande
Lung Foundation Australia – Lizotte Family Research Grant: Dr. Peter Bell
PACT Grant-In-Aid: Dr Hayley Barnes and Dr Ryan Hoy
CREATE Hope Fellowship (scientific): Dr Gang Liu
CREATE Hope Fellowship (clinical): Dr Ingrid Cox
LUCAP PhD Topup: Dr Jess Nash

The Hope Research Fund aims to not only invest in discovering scientific breakthroughs but bring new hope to millions of Australians impacted by lung disease and lung cancer. 

Lung Foundation Australia Launched the Hope Research Fund last year with the vision of creating Australia’s leading national long-term commitment to fund life-changing lung disease and cancer research, which is severely underfunded. 

With a goal of raising $50 million by 2030, the Hope Research Fund relies heavily on the generosity of Gifts in Wills to fund this life changing research. 

TSANZ Members Success with NHMRC Grant Funding

TSANZ wishes to extend our congratulations to the TSANZ Members who were awarded NHMRC Clinical Trials and Cohort Studies Grants. Over $75.3 million in funding was granted to support 33 clinical trials and cohort studies. It was excellent to see some of this go towards respiratory research. 

Professor Gregory Fox, from the University of Sydney was awarded $4.77 million for The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis. From Professor Fox; “Tuberculosis (TB) is an infectious respiratory disease affecting 10 million people each year worldwide. Resistance to isoniazid, one of the most important first-line antibiotics used to treat TB, leads to increased mortality and more advanced drug resistance. We will undertake the first clinical trial to evaluate the effectiveness of new-generation fluoroquinolones antibiotics in treating isoniazid-resistant TB. This trial will be conducted in Australia, Vietnam and Canada.”

Dr Danielle Wurzel, from the University of Melbourne was awarded $3.72 million for Translatable Evidence To Improve Lung Health Outcomes In First Nations People – A Cohort Study From Birth to 6 Years. From Dr Wurzel; “First Nations children have unacceptably high rates of lung disease which means poorer adult health. Our project, co-designed with Aboriginal researchers, scientists and clinicians, will address the disproportionate burden of lung disease in First Nations People. Through a birth cohort study of First Nations People we will evaluate a range of exposures and biomarkers for lung health indicators to identify high-risk children. This research will inform interventions to prevent early-onset chronic lung diseases and will assist clinicians, researchers and policy makers in our shared vision to Close the Gap. Other TSANZ members who are Chief investigators on this project are Prof Shyamali Dharmage (UoM), Prof Anne Chang (QUT), Prof Paul Robinson (UoS), (QIMR) and Dr Gabrielle McCallum (Menzies).”

Associate Professor Adrian Lowe, from the University of Melbourne was awarded $7.56 million of Testing an implementable strategy to improve infant skin barrier to prevent asthma and preserve lung function: a 4-year follow-up of the existing PEBBLES RCT. From Associate Professor Lowe; “Childhood asthma is a major public health problem worldwide, and poor lung function in childhood increases the risk of chronic adult lung disease and early death. There are currently limited strategies to prevent children developing asthma and early lung function deficits. It has been hypothesised that impaired skin barrier in early life can increase risk of allergic sensitisation and asthma.  In this follow-on study of our large NHMRC funded trial, we will test if an intervention to improve skin barrier can reduce early life asthma and lung function deficits.”

External Grant Opportunities

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 2: May 26, 2022

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Physiotherapy and exercise management of patients undergoing thoracic surgery across the continuum

This research project is aiming to describe the current practices of exercise health professionals (e.g., physiotherapy, exercise physiology, allied health assistants) when assessing and managing patients undergoing thoracic surgery for lung cancer across all phases of the treatment continuum (pre-operative to 12 months post-operative).  

You are invited to participate in this project if you are a registered exercise health professional working with people with lung cancer undergoing thoracic surgery across the continuum of care, including pre-operative, post-operative acute, and community/outpatient programs (e.g., pulmonary rehabilitation and/or oncology rehabilitation).  On completion of this survey, you will be given the opportunity to enter the draw to win a new Apple iPad. 

The survey will close on July 22nd.

To complete the survey and to read the Plain Language Statement please visit https://bit.ly/thoracicsurgsurvey.

For further information, please contact A/Professor Catherine Granger Catherine.Granger@unimelb.edu.au or Georgina Whish-Wilson gwhishwilson@student.unimelb.edu.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.06 – JULY 2022

VOLUME 6.05 – JULY 2021

Research Roundup:

May 2021

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. It was fantastic to see so many people tune-in to our first ever virtual conference earlier this month. I would like to offer a huge congratulations to everyone who has continued to champion respiratory research by adapting approaches and pushing through despite the COVID-19 pandemic. The presentations on display were testimony to our society of dedicated and steadfast professionals.

I am honoured to be taking over as Chair of the Research Sub-Committee from Professor Sandy Hodge, who has done a brilliant job of leading our collective interests over the past four years. If there is anything the committee or I can do to help support your research activities, please do not hesitate to get in touch.

We are please to announce that over $300,000 has been awarded for respiratory research excellence in 2021. Huge congratulations to all the award recipients and good luck with your research. Two awards are currently open, being a TSANZ and National Asthma Council Australia Career Development Fellowship and a NZ Branch travel grant closing 31st of May and 8th of August respectively. There is an Asthma Australia Research Grant and Workshop on offer later this month and calls for applicants in the 2021 Australian Museum Eureka Prizes are open until the 28th of May.

Check out The Limbic, Respirology Editor’s Choice and Respiratory Research Review segments for a snapshot of some great respiratory research going on. Finally, if you have an interest in lung cancer care, acute exacerbations of COPD or helping to inform the top 10 research priorities for pulmonary fibrosis, click on the survey links below.

Enjoy the May edition of your Research Roundup.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

$300,000 FOR LUNG DISEASE RESEARCH ANNOUNCED

(Saturday, 1st May 2021): Over $300,000 in lung research investment was announced this weekend at the Respiratory Research Excellence Awards, presented in a virtual format alongside the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science (TSANZSRS 2021).

This prestigious selection of awards are presented to TSANZ members who are at various stages of their career and doing outstanding work. These awards aim to support individuals through project funding, fellowships and travel grants.

“This funding enables our researchers to learn more and develop their skills, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” said TSANZ President Elect Professor John Upham.

“We’re honoured to be able to support some of Australia’s most innovative researchers working on lung disease and lung health. This research will make a difference to the lives of the 1 in 4 Australians with lung disease,” he said.

Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of TSANZSRS – are pleased to announce awards from Cystic Fibrosis Australia, the National Asthma Council Australia, Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis.

“The TSANZ is privileged to support a diverse awards program that recognises the best and brightest minds in respiratory health that will shape the lung health of our communities into the future” said TSANZ CEO, Dr Graham Hall.

The research awards are supported by the generosity of private donations, sponsorship and leveraged financing from recipients’ institutions. Thank you to our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge and build capacity in the respiratory workforce, with the overall goal to prevent, cure and relieve disability from lung disease.

2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

TSANZ would like to congratulate the following Award winners.

TSANZ Janet Elder Travel Award – Early  Career – Maggie Lam, Monash University

TSANZ Janet Elder Travel Award – Early Career – Melissa Preissner, Monash University

TSANZ Janet Elder Travel Award – Early Career – Mariana Hoffman Barbosa, Monash University

BI NZ Primary Care Grant – Sarah Mooney, Auckland University of Technology

Past President’s Scholarship Award – Elena Schneider-Futschik, The University of Melbourne

TSANZ Peter Phelan Research Award – Thomas Iosifidis, Curtin University and Telethon Kids Institute

TSANZ/Maurice Blackburn GIA – Keshav Raj Paudel, University of Technology Sydney

TSANZ Robert Pierce GIA for ILH – Peter Wark, University of Newcastle and Hunter Medical Research Institute

Ann Woolcock New Investigator Award – Nicole Sheers, Austin Health, University of Melbourne

CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Gang Liu, Ashleigh Philp & Laura Glenn, UTS, UNSW & The University of Sydney

CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Laura Glenn, Alan Teoh, Hayley Barnes & John Mackintosh, RPAH, Alfred Health & Prince Charles Hospital

PACT Grant-in-Aid For Investigator Led Pulmonary Fibrosis Clinical Research (Lung Foundation Australia and CRE-PF) – Yet Hong Khor & Christopher Ryerson, Austin Health & University of British Columbia

CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Joanna Lee, Monash University

CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Claudia Sim, Monash University

Open Awards

Thoracic Society Awards

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

TSANZ NZ Branch ASM 2021 Travel Grant – closing 8 August 2021

Asthma Australia Research Grant and Workshop

Asthma Australia would like to invite you to a workshop which aims to share ideas and invoke research partnerships around issues relevant to people disproportionately affected by asthma. At the end of the meeting, Asthma Australia will re-announce a $300,000 Strategic Alliance grant for such work.

At Asthma Australia, we are committed to doing things differently in our quest to help people live freely from their disease and hope you are ready to join us. Thanks to the Ray O’Donnell Belgrave Lions Asthma Research Fund, we are seeking to fund research from Victorian-led research collaborations to answer the evidence gaps and develop solutions for people from the three following population segments disproportionately affected by asthma:

  • Aboriginal and Torres Strait Islander People
  • People facing socioeconomic disadvantage
  • People from culturally and linguistically diverse backgrounds.

We will be holding one workshop (up to 90 minutes) for each population segment and want you to attend.

At the workshops you will hear why this research funding is a priority in Australia for people with asthma. We will facilitate a discussion among participants about why these inequities persist and share ideas around potential collaborations and novel approaches that aim to address them. After the workshops, applications will open to apply for the $300,000 Strategic Alliance Grant. 

    Workshop  details

    1. Culturally and linguistically diverse backgrounds

    When: Wednesday 26th May 11-12:30
    Where: Ethnic Community Council Victoria

    1. People facing socioeconomic disadvantage
      Tuesday 25th May 2-3:30pm
    1. Aboriginal and Torres Strait Islander People
      TBC – please register interest

    If you are interested in applying for this grant, please contact Asthma Australia (via research@asthma.org.auwith your name, organisation and the workshop you would like to attend.  

    2021 Australian Museum Eureka Prizes

    Do you know someone making a difference in their field?

    Entries to the 2021 Australian Museum Eureka Prizes are now open!

    This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

    There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

    If you know an individual or team doing outstanding work, why not encourage them to enter?

    Entries close 7pm AEST Friday 28 May

    VIEW THE FULL PRIZE PROGRAM

    Respirology – Editor’s Choice

    Respirology Issue 26.4 April 2021

    Central airway collapse is related to obesity independent of asthma phenotype

    Swati A. Bhatawadekar, Ubong Peters, Ryan R. Walsh, Nirav Daphtary, Erick S. Maclean, Vitor Mori, Kevin Hodgdon, C. Matthew Kinsey, David A. Kaminsky, Jason H.T. Bates and Anne E. Dixon

    DOI: 10.1111/resp.14005

    Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

    Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, and Takafumi Suda

    DOI: 10.1111/resp.13978

    Surveys and Research

    SURVEY OF LUNG CANCER CARE IN AUSTRALIA

    We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

    • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
    • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
    • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

    Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

    Thank you for your time.

    Prof Fraser Brims
    Curtin Medical School
    fraser.brims@curtin.edu.au 

    GP PARTICIPATION REQUIRED

    Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.

    Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. We are seeking GPs to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients. Due to the current COVID-19 vaccination rollout across Australia, it is very challenging to secure participation. Any assistance to distribute this among your contacts is greatly appreciated.

    All eligible participants who complete the survey will have the chance to win one of two $250 gift vouchers, and anyone who completes an optional follow-up qualitative interview will receive a $250 gift voucher.

    The survey can be accessed by clicking HERE.

    The survey has been approved by the Monash University Human Research Ethics Committee (MUHREC ref. 26571). If you have any queries, please contact Dr Bianca Perera at bianca.perera@monash.edu, Dr. Chris Barton at chris.barton@monash.edu or Dr Christian Osadnik (Principal investigator) at christian.osadnik@monash.edu.

     

    TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

    A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

    This study has now been completed and below is a summary of the findings from this work.

    The top 3 priorities rank by people with PF and caregivers were:

    1. What medications can reverse scarring in the lungs of people with PF?
    2. What medications can improve lung function in people with PF?
    3. What are the causes of PF?

    The top 3 priorities rank by people with healthcare professionals/researchers were:

    1. What medications can reverse scarring in the lungs of people with PF?
    2. How can we prevent PF?
    3. What are the causes of PF?

    The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

    (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

    The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

    Yours sincerely,

    Anne Holland
    Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

    TBPod

    The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

    Can you help TSANZ make a difference?

    Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

    1. Making a donation to our Benevolent Fund

    The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
    CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

    2. Making a donation to support research

    With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
    Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

    3. Establishing a named award

    For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

    4. Leave TSANZ a gift in your will

    If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
    If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

    5. TSANZ New Zealand Branch Incorporated 

    New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
    CLICK HERE to make a donation.

    Thank you for your continued support of TSANZ.

    VOLUME 7.06 – JULY 2022

    VOLUME 6.04 – MAY 2021

    Research Roundup:

    May 2021

    Welcome Message

    Welcome to another edition of our TSANZ Research Roundup. It was fantastic to see so many people tune-in to our first ever virtual conference earlier this month. I would like to offer a huge congratulations to everyone who has continued to champion respiratory research by adapting approaches and pushing through despite the COVID-19 pandemic. The presentations on display were testimony to our society of dedicated and steadfast professionals.

    I am honoured to be taking over as Chair of the Research Sub-Committee from Professor Sandy Hodge, who has done a brilliant job of leading our collective interests over the past four years. If there is anything the committee or I can do to help support your research activities, please do not hesitate to get in touch.

    We are please to announce that over $300,000 has been awarded for respiratory research excellence in 2021. Huge congratulations to all the award recipients and good luck with your research. Two awards are currently open, being a TSANZ and National Asthma Council Australia Career Development Fellowship and a NZ Branch travel grant closing 31st of May and 8th of August respectively. There is an Asthma Australia Research Grant and Workshop on offer later this month and calls for applicants in the 2021 Australian Museum Eureka Prizes are open until the 28th of May.

    Check out The Limbic, Respirology Editor’s Choice and Respiratory Research Review segments for a snapshot of some great respiratory research going on. Finally, if you have an interest in lung cancer care, acute exacerbations of COPD or helping to inform the top 10 research priorities for pulmonary fibrosis, click on the survey links below.

    Enjoy the May edition of your Research Roundup.

    A/Prof Kristin Carson-Chahhoud
    Chair, Research Sub-Committee 

    2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

    $300,000 FOR LUNG DISEASE RESEARCH ANNOUNCED

    (Saturday, 1st May 2021): Over $300,000 in lung research investment was announced this weekend at the Respiratory Research Excellence Awards, presented in a virtual format alongside the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science (TSANZSRS 2021).

    This prestigious selection of awards are presented to TSANZ members who are at various stages of their career and doing outstanding work. These awards aim to support individuals through project funding, fellowships and travel grants.

    “This funding enables our researchers to learn more and develop their skills, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” said TSANZ President Elect Professor John Upham.

    “We’re honoured to be able to support some of Australia’s most innovative researchers working on lung disease and lung health. This research will make a difference to the lives of the 1 in 4 Australians with lung disease,” he said.

    Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of TSANZSRS – are pleased to announce awards from Cystic Fibrosis Australia, the National Asthma Council Australia, Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis.

    “The TSANZ is privileged to support a diverse awards program that recognises the best and brightest minds in respiratory health that will shape the lung health of our communities into the future” said TSANZ CEO, Dr Graham Hall.

    The research awards are supported by the generosity of private donations, sponsorship and leveraged financing from recipients’ institutions. Thank you to our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge and build capacity in the respiratory workforce, with the overall goal to prevent, cure and relieve disability from lung disease.

    2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

    TSANZ would like to congratulate the following Award winners.

    TSANZ Janet Elder Travel Award – Early  Career – Maggie Lam, Monash University

    TSANZ Janet Elder Travel Award – Early Career – Melissa Preissner, Monash University

    TSANZ Janet Elder Travel Award – Early Career – Mariana Hoffman Barbosa, Monash University

    BI NZ Primary Care Grant – Sarah Mooney, Auckland University of Technology

    Past President’s Scholarship Award – Elena Schneider-Futschik, The University of Melbourne

    TSANZ Peter Phelan Research Award – Thomas Iosifidis, Curtin University and Telethon Kids Institute

    TSANZ/Maurice Blackburn GIA – Keshav Raj Paudel, University of Technology Sydney

    TSANZ Robert Pierce GIA for ILH – Peter Wark, University of Newcastle and Hunter Medical Research Institute

    Ann Woolcock New Investigator Award – Nicole Sheers, Austin Health, University of Melbourne

    CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Gang Liu, Ashleigh Philp & Laura Glenn, UTS, UNSW & The University of Sydney

    CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Laura Glenn, Alan Teoh, Hayley Barnes & John Mackintosh, RPAH, Alfred Health & Prince Charles Hospital

    PACT Grant-in-Aid For Investigator Led Pulmonary Fibrosis Clinical Research (Lung Foundation Australia and CRE-PF) – Yet Hong Khor & Christopher Ryerson, Austin Health & University of British Columbia

    CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Joanna Lee, Monash University

    CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Claudia Sim, Monash University

    Open Awards

    Thoracic Society Awards

    TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

    TSANZ NZ Branch ASM 2021 Travel Grant – closing 8 August 2021

    Asthma Australia Research Grant and Workshop

    Asthma Australia would like to invite you to a workshop which aims to share ideas and invoke research partnerships around issues relevant to people disproportionately affected by asthma. At the end of the meeting, Asthma Australia will re-announce a $300,000 Strategic Alliance grant for such work.

    At Asthma Australia, we are committed to doing things differently in our quest to help people live freely from their disease and hope you are ready to join us. Thanks to the Ray O’Donnell Belgrave Lions Asthma Research Fund, we are seeking to fund research from Victorian-led research collaborations to answer the evidence gaps and develop solutions for people from the three following population segments disproportionately affected by asthma:

    • Aboriginal and Torres Strait Islander People
    • People facing socioeconomic disadvantage
    • People from culturally and linguistically diverse backgrounds.

    We will be holding one workshop (up to 90 minutes) for each population segment and want you to attend.

    At the workshops you will hear why this research funding is a priority in Australia for people with asthma. We will facilitate a discussion among participants about why these inequities persist and share ideas around potential collaborations and novel approaches that aim to address them. After the workshops, applications will open to apply for the $300,000 Strategic Alliance Grant. 

      Workshop  details

      1. Culturally and linguistically diverse backgrounds

      When: Wednesday 26th May 11-12:30
      Where: Ethnic Community Council Victoria

      1. People facing socioeconomic disadvantage
        Tuesday 25th May 2-3:30pm
      1. Aboriginal and Torres Strait Islander People
        TBC – please register interest

      If you are interested in applying for this grant, please contact Asthma Australia (via research@asthma.org.auwith your name, organisation and the workshop you would like to attend.  

      2021 Australian Museum Eureka Prizes

      Do you know someone making a difference in their field?

      Entries to the 2021 Australian Museum Eureka Prizes are now open!

      This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

      There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

      If you know an individual or team doing outstanding work, why not encourage them to enter?

      Entries close 7pm AEST Friday 28 May

      VIEW THE FULL PRIZE PROGRAM

      Respirology – Editor’s Choice

      Respirology Issue 26.4 April 2021

      Central airway collapse is related to obesity independent of asthma phenotype

      Swati A. Bhatawadekar, Ubong Peters, Ryan R. Walsh, Nirav Daphtary, Erick S. Maclean, Vitor Mori, Kevin Hodgdon, C. Matthew Kinsey, David A. Kaminsky, Jason H.T. Bates and Anne E. Dixon

      DOI: 10.1111/resp.14005

      Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

      Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, and Takafumi Suda

      DOI: 10.1111/resp.13978

      Surveys and Research

      SURVEY OF LUNG CANCER CARE IN AUSTRALIA

      We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

      • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
      • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
      • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

      Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

      Thank you for your time.

      Prof Fraser Brims
      Curtin Medical School
      fraser.brims@curtin.edu.au 

      GP PARTICIPATION REQUIRED

      Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.

      Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. We are seeking GPs to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients. Due to the current COVID-19 vaccination rollout across Australia, it is very challenging to secure participation. Any assistance to distribute this among your contacts is greatly appreciated.

      All eligible participants who complete the survey will have the chance to win one of two $250 gift vouchers, and anyone who completes an optional follow-up qualitative interview will receive a $250 gift voucher.

      The survey can be accessed by clicking HERE.

      The survey has been approved by the Monash University Human Research Ethics Committee (MUHREC ref. 26571). If you have any queries, please contact Dr Bianca Perera at bianca.perera@monash.edu, Dr. Chris Barton at chris.barton@monash.edu or Dr Christian Osadnik (Principal investigator) at christian.osadnik@monash.edu.

       

      TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

      A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

      This study has now been completed and below is a summary of the findings from this work.

      The top 3 priorities rank by people with PF and caregivers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. What medications can improve lung function in people with PF?
      3. What are the causes of PF?

      The top 3 priorities rank by people with healthcare professionals/researchers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. How can we prevent PF?
      3. What are the causes of PF?

      The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

      (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

      The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

      Yours sincerely,

      Anne Holland
      Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

      TBPod

      The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

      Can you help TSANZ make a difference?

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

      VOLUME 7.06 – JULY 2022

      VOLUME 5.04 – JUNE 2020

      Research Roundup:

      June 2020

       

      Welcome Message

      Welcome to this exciting update of the Research Roundup.

      Many of you would have experienced the success of our first virtual Ann Woolcock Award presentation session. I congratulate all the finalists for adapting so well to this new format and to the audience who quickly settled into the Zoom Q&A system and challenged the speakers with stimulating questions.

      The RSC members are having a well-earned break from their arduous but rewarding grant review duties, and both I and the Society sincerely thank these members for all their hard work. Their break will be short as awards will open again in the coming months.

      Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

      Enjoy the June edition of your Research Roundup.

      Prof Sandra Hodge

      Chair, Research Sub-Committee

      2020 Respiratory Research Excellence Awards

       

      TSANZ congratulates the following award winners!!!

       

      Ann Woolcock New Investigator Award Winner: Kurtis Budden

      Ann Woolcock New Investigator Award Finalists: Kak-Ming Ling, Rebecca Stockwell, Steven Taylor, Pamela Laird, Razia Zakarya

      TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship: Simon Craig

      TSANZ/AstraZeneca Respiratory Research Mid-Career Fellowship: Hayley Scott

      TSANZ/AstraZeneca Respiratory Research Early Career Fellowship: Steven Taylor

      Australian Cystic Fibrosis Research Trust 2020 Innovation Grant: Abdullah Tarique, Peter Sly, Emmanuelle Fantino, Clair Wainwright, and Scott Bell

      Vertex Adult Cystic Fibrosis Research Award: Sandra Hodge, Peter Zalewski, David Parsons, Andrew Tai, Sally Chapman, Judith Morton, and Emily Hopkins

      Vertex Paediatric Cystic Fibrosis Research Award: Shafagh Waters and Adam Jaffe

      Maurice Blackburn Grant-in-Aid for Occupational Lung Disease: Mariane T Turner, Samuel Sameh, Robert A Cohen, and Deborah H Yates           

      TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health: Kristin Carson-Chahhoud

      TSANZ Peter Phelan Paediatric Research Award: Shivanthan Shanthikumar

      TSANZ / Boehringer Ingelheim Australia COPD Travel Award: Katrina Tonga

      TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award: Hajar Ali

      TSANZ/JRS Early Career Development Award: Saleela Ruwanpura

      Janet Elder International Mid-Career Travel Award: David G Chapman

      Janet Elder International Early Career Travel Award Recipient 1: Steven Taylor

      Janet Elder International Early Career Travel Award Recipient 2: Tony Zhang

      TSANZ Respiratory Nurses Career Development Award for Indigenous Research:Kobi Schutz

       

      TSANZ would like to thank our partners and sponsors for their support of excellent respiratory research and researchers!

      2020 TSANZ Awards by Nomination

      At TSANZ 2020 AGM we recognised seven leaders in their field of lung health.

      TSANZ 50th Anniversary Medal for Education and Training – Associate Professor David Fielding.

      The 50th Anniversary Medal is awarded each year in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand.

      TSANZ Research Medal – Professor Shyamali Dharmage, Professor Alan James

      This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand. This year, due to the calibre of nominations, the TSANZ Board has chosen two recipients for the TSANZ Research Medal.

      TSANZ Society Medal – Associate Professor Tara Mackenzie

      This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand.

      Fellowships

      • Professor Richard Beasley
      • Professor Margaret Wilsher
      • Professor Ross Vlahos

      Each year the TSANZ board considers peer nominations for Fellow status of the Thoracic Society of Australia and New Zealand (TSANZ). Fellow status is awarded to members who have demonstrated exceptional contributions to the field of respiratory health in Australia or New Zealand.

      Congratulations to all!

      Respirology – Editor’s Choice 

      Respirology Issue 25.5 May 2020

       

      Artificial stone-associated silicosis in China: A prospective comparison with natural stone-associated silicosis

      Na Wu, Changjiang Xue, Shiwen Yu and Qiao Ye

       

      Chest HRCT of 2 peatients with natural stone-associated findings (top) and 2 patients with artificial stone-associated silicosis (Bottom)

      DOI: 10.1111/resp.13744

       

      Acute exacerbations of fibrotic interstitial lung diseases

      Atsushi Suzuki, Yasuhiro Kondoh, Kevin K. Brown, Takeshi Johkoh, Kensuke Kataoka, Junya Fukuoka, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Jun Fukihara, Masahiko Ando, Tomonori Tanaka, Naozumi Hashimoto, Koji Sakamoto and Yoshinori Hasegawa

       

      Researchers from the ILD collaborative team from Japan and US. From left to right: (front) Dr. Yasuhiro Kondoh, Dr. Kevin K. Brown, Dr. Yoshinori Hasegawa; (back) Dr. Atsushi Suzuki, Dr. Koji Sakamoto, Dr. Naozumi Hashimoto, Dr. Kensuke Kataoka, Dr. Yuji Saito.

      DOI: 10.1111/resp.13682

      Respirology Issue 25.6 June 2020

       

      Effects of E-cigarette E-liquid components on bronchial epithelial cells: Demonstration of dysfunctional efferocytosis

      Miranda P. Ween, Rhys Hamon, Matthew G, Macowan, Leigh Thredgold, Paul R. Reynolds and Sandra J. Hodge

       

      A collection of e-cigarettes and e-liquids for sale to vapers

      DOI: 10.1111/resp.13696

       

      Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF

      Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J. Butte and Harold R. Collard

       

       

      The research team from the University of California San Francisco in the United States (c269928 represents Brett Ley)

      DOI: 10.1111/resp.13753

      TSANZSRS 2020 Abstracts

      Due to the COVID-19 pandemic, the TSANZSRS 2020 ASM has been postponed until 30 April – 4 May 2021. This supplement contains Abstracts that were accepted for presentation at the 2020 meeting.

      Volume 25, Issue S1 TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, 27–31 March 202

       

      Invitations and surveys

       

      CYSTIC FIBROSIS RESEARCH AND ADVOCACY PRIORITY SETTING SURVEY 2020 AND BEYOND

      Dear Members of the Thoracic Society of Australia and New Zealand,

      Cystic Fibrosis Australia (CFA) is inviting the TSANZ members to take part in their Research and Advocacy Priority Setting survey. If you are a CF stakeholder, living with the condition or looking after someone who lives with the condition, then your survey responses are greatly needed and encouraged.

      https://www.surveymonkey.com/r/F38Q8K2

      We want all our community members, patients, carers, clinicians and researchers to be involved in every step and we thank you for agreeing to take part.

      To speak to us about this questionnaire or for any further enquires, contact us at (02) 9889 5171 or email nickim@cfa.org.au. Alternatively, you can join the conversation over at the Cystic Fibrosis Australia page on Facebook.

       

      INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

      Dear colleagues,

      Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

      To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

      We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

      In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

      • 1-3: Outcomes of limited importance.
      • 4-6: Outcomes that are important but not critical.
      • 7-9: Critical outcomes.

      We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

      In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

      Your opinion in both surveys is extremely important in developing the core outcome set.

      It is crucial that you complete both surveys and we would be very grateful if you can do this.

      Please, take the survey in one of the following languages:

      English: https://delphimanager.liv.ac.uk/COPD/
      Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
      German: https://delphimanager.liv.ac.uk/COPD-GE/
      Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
      Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
      Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
      Russian: https://delphimanager.liv.ac.uk/COPD-RU/
      Greek: https://delphimanager.liv.ac.uk/COPD-GR/
      Danish: https://delphimanager.liv.ac.uk/COPD-DK/
      Italian: https://delphimanager.liv.ac.uk/COPD-IT/

      We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

      Thank you very much in advance,
      Kind regards,
      Associate Prof. Jens-Ulrik Jensen,
      Dr. Alexander Mathioudakis,
      Prof. Jørgen Vestbo,
      On behalf of the study team.

       

      NURSES’ ATTITUDES TO CARING FOR PEOPLE WITH INTELLECTUAL DISABILITY: AN AUSTRALIAN SURVEY

      Dear Colleagues,

      We invite you to consider participating in our online survey focused on nurses’ attitudes to caring for people with intellectual disability. This survey, led by researchers from Western Sydney and Central Queensland Universities, is a replication of a previous US study by Dr Melissa Desroches from the University of Massachusetts, Dartmouth.

      People with intellectual disability have lower levels of general health than other members of our community. They also have higher incidence of hospitalisation and, of major concern, higher incidence of preventable death than members of the general population.

      By learning about nurses’ attitudes to caring for people with intellectual disability, we anticipate being able to develop models of care and supportive resources for nurses to enhance the care that they provide to people with intellectual disability.

      Please read the attached participant information sheet and consider completing this short survey by accessing the link below:

      Caring for People with Intellectual Disability survey

      Thank you for considering our invitation
      A/Prof Nathan Wilson, Western Sydney University
      Dr Peter Lewis, Western Sydney University
      Ms Virginia Howie, Central Queensland University
      Dr Melissa Desroches, University of Massachusetts, Dartmouth

      Kind regards,
      Virginia

       

      GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

      Dear Colleague, 

      You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

      We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

      Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

      If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

      THANK YOU!
      Jaber Alqahtani
      On behalf of the whole international team

       

      INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

      Dear Members of the Thoracic Society of Australia and New Zealand, 

      Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

      Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

      Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

      The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

      If you are interested in participating or would like further information on this study, please contact: 

      Professor Anne Holland (Chief Investigator) 
      Professor of Physiotherapy, 
      Monash University and Alfred Health 
      Email: Anne.Holland@monash.edu 
      Telephone: (03) 9903 0214 

      Ms Joanna Lee (PhD candidate)
      Monash University and Alfred Health
      Email: joanna.lee2@monash.edu
      Mobile: 0431 689 361

      Thank you for your time and consideration of our study. 

       

      IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

      What are the barriers and facilitators to implementing best practice?

      Dear Members of the Thoracic Society of Australia and New Zealand,

      The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

      Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

      Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

      Like more information or interested in participating? Click here

      The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

      If you would like to speak to us about any aspect of this study, please contact:

      Professor Anne Holland
      Professor of Physiotherapy, Monash University and Alfred Health
      Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University
      Anne.Holland@monash.edu or (03) 9903 0214

      Thank you for your time and consideration of our study.

      ASCOT trial

      ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

      The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

      Potential Treatments for COVID-19

      There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

      ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

      ASCOT Trial Intervention

      Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

      1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
      1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

       

      Protocol documents and further details are available at www.ascot-trial.edu.au

       

      Can you help TSANZ make a difference?
       

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

       

      .

       

      VOLUME 7.06 – JULY 2022

      VOLUME 3.02 MARCH 2018

      Research Roundup:

      March 2018

      .
       

      Welcome Message

      March – the month of NHMRC project grant submissions and the TSANZSRS18. We hope that all grants where submitted smoothly yesterday. Please take a moment to register for the conference!

      We would like to highlight that this year we will be holding the inaugural Respiratory Research Excellence Awards which you are all invited to and encouraged to attend. Please join us and show your support and thanks to your colleagues, collaborators, and our sponsors. This session is in lieu of all ASM Awards sessions which have previously occurred over the duration of the conference, thus allowing more time in the program for research presentations, discussion and collaboration. Due to this change, SIG awards will be announced following the ASM by the TSANZ Central Office.

      We wish you all the best in your preparation. See you in Adelaide.

      Enjoy the March edition of your research roundup.

      Prof Phil Hansbro

      Prof Sandra Hodge

      Co-Chairs, Research Sub-Committee

       

       

      Open Awards

      Vertex Cystic Fibrosis Research Awards

      Lung Foundation Australia / A Menarini Pty Ltd 2018 Travel Awards

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      Watch this space for more award announcements…

      Respirology Issue 23.3 – Editor’s Choice

      Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma

      Andreas S. Lappas, Anna S. Tzortzi, Efstathia M. Konstantinidi, Stephanie I. Teloniatis, Chara K. Tzavara, Sofia A. Gennimata, Nikolaos G. Koulouris, Panagiotis K. Behrakis

      DOI: 10.1111/resp.13180

       

      The Greek study team at the George D. Behrakis RESEARCH LAB in Athens. From left to right – seated: Panagiotis K Behrakis, Anna Tzortzi and Nikolaos G Koulouris ; standing: Chara K Tzavara, Stephanie I Teloniatis, Sofia A Gennimata, Efstathia Konstantinidi and Andreas Lappas.

       

      Unfavourable outcome of glucocorticoid treatment in suspected idiopathic pulmonary fibrosis

      Ivo A. Wiertz, Wim A. Wuyts, Coline H.M. van Moorsel, Adriane D.M. Vorselaars, Hendrik W. van Es,

      Matthijs F.M. van Oosterhout, Jan C. Grutters

      DOI: 10.1111/resp.13230

       

      Unfavourable outcome of prednisone treatment in possible idiopathic pulmonary fibrosis patients

      Medical Research Future Fund Grants

      The Medical Research Future Fund (MRFF) is providing grants of financial assistance to support health and medical research and innovation, with the objective of improving the health and wellbeing of Australians.

      The MRFF Low Survival Cancers and Diseases (LSCD) Grant Opportunity opened on  the 7th of March 2018 and will close at 5pm AEST on Wednesday 18 April 2018.

      TSANZ is willing to partner with members on suitable (subject to review) MRFF projects, offering in-kind support by way of:

      • providing guidance in meeting the requirements of the grant
      • assistance in review of progress and data
      • promotion of the trial among members
      • meeting support for investigators
      • access to a conference call system (video or teleconference)
      • access to a venue for face to face meetings

      Please contact hayley.see@thoracic.org.au to discuss partnership possibilities.

      The Children’s Hospital at Westmead: CF Research Funding

      Funding is available for new or existing projects in paediatric Cystic Fibrosis to be conducted at the Children’s Hospital at Westmead. Application form Deadline: 23rd March, 2018 5pm AEDT.

      For more information contact peter.cooper@health.nsw.gov.au

      Research Project and Survey Requests

      Explaining chronic breathlessness

      Chronic breathlessness has been defined as ‘breathlessness that persists despite optimal treatment of underlying pathology and results in disability’ (Johnson et al. Eur Respir J 2017;49 (5)). This symptom is a common daily experience for people with a range of malignant and non-malignant respiratory, cardiovascular and neuromuscular conditions.

      We know very little about how health professionals explain chronic breathlessness to people living with this symptom. This survey seek to collect information on the  explanations health professionals, from a variety of professional disciplines, use when explaining chronic breathlessness  to people living with this symptom (and their views on whether there is specific information which should  and should not be included in explanations). 

      This electronic survey contains 13 questions and should take not more than 10 -12 minutes to complete. All responses will be confidential and anonymised by allocating an ID code to each participant. Details concerning the process including data management and privacy consideration are included in the Participant Information sheet included within the opening screens of the survey.

      Ethical approval has been received from the Human Research Ethics Committee of the University of South Australia (ID: 200896)

      For further information or to participate, please click here: 

      Explain chronic breathlessness’   or copy and paste the following into your browser:

      https://www.surveymonkey.com/r/Explain-Chronic-Breathlessness

      For further information please contact Dr Marie Williams (E: marie.williams@unisa.edu.au or Ph: +61-8-8302 1153, University of South Australia) on behalf of the research team (Dr Kylie Johnston and Prof Dina Brooks)

       

      ‘Usual’ antenatal asthma management

      Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma managementconsists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

      If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

      Ethics approval has been granted for this study (NSW HREC Reference No: HREC/16/HNE/394).  All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

      Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser:

      https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

      Thank you,

      Dr Vanessa Murphy, Vanessa.Murphy@newcastle.edu.au
      Ms Karen McLaughlin, Karen.McLaughlin@hnehealth.nsw.gov.au

      Australian Lung Cancer Conference

       

       

      Register to hear the latest evidence-based information on the impact of immune-oncology, ALK, EGFR and ROS 1, staging of lung cancer, managing toxicity, stigma and survivorship and surgery.

      The program features international speakers including:

      • A/Prof Marianne Davies, Acute Nurse Practitioner, Yale University School of Nursing
      • Dr Hisao Asamura, Thoracic Surgeon, Tokyo National Cancer Centre Hospital
      • Dr Jose Belderbos, Radiation Oncologist, Netherlands Cancer Institute
      • A/Prof Justin Gainor, Medical Oncologist, Massachusetts General Hospital
      • Prof Tony Mok, Medical Oncologist, Chinese University of Hong Kong
      • Prof Thomas Lynch, Medical Oncologist, Yale Cancer Centre.

      Click here for the full program. Please note: this is currently being updated.

      Industry Sponsored Symposiums

      Seven Industry Sponsored Symposiums will be hosted as part of the ALCC including:

      • Pfizer evening symposium – Thursday 5 April
      • AstraZeneca morning symposium – Friday 6 April
      • Roche lunch symposium – Friday 6 April
      • BMS evening symposium – Friday 6 April
      • Slater and Gordon evening symposium – Friday 6 April
      • MSD morning symposium – Saturday 7 April
      • Roche-Foundation Medicine lunch symposium – Saturday 7 April

      When registering be sure to select the industry sponsored symposium you would like to attend. If you would like to amend your registration to change or include these, please email Amelia Parsons via ameliap@lungfoundation.com.au

      Australia New Zealand Lung Cancer Nurses Forum (ANZ-LCNF) Workshop

      The workshop will be held on Thursday 5 April featuring international nurse speaker A/Prof Marianne Davies. Key topics include:

      • Importance of understanding biomarkers
      • Immunotherapy from the nurses perspective
      • Targeted therapies
      • Self-care for health care professionals
      • The latest in mesothelioma

      Faculty of Radiation Oncology Lung Interest Cooperative (FROLIC) Workshop
      Join the FROLIC committee for the first workshop at the Australian Lung Cancer Conference, featuring international radiation oncologist Dr Jose Beldebos. Topics include:

      • Thoracic radiotherapy for Stage I-III small cell lung cancer
      • Future directions for radiation therapy in Stage III non-small cell lung cancer
      • Future directions for SABR in Stage I non-small cell lung cancer

      Click Here to Register Now

       
       
       
       
       
       
       
       
       

      .

      VOLUME 7.06 – JULY 2022

      VOLUME 2.9 NOVEMBER 2017

      Research Roundup:

      November  2017

      .
       

      Welcome Message

      We are pleased to announce the launch of the TSANZ 50th Anniversary Benevolent Grant!

      The 50th Anniversary TSANZ Benevolent Fund was established in 2011 when the Thoracic Society became a Health Promotion Charity. Through this fund the TSANZ can contribute to worthwhile causes by supporting philanthropic activities which improve respiratory health care delivery locally and around the world. Thank you to all of our wonderful TSANZ members who have been donating to the Benevolent Fund. This grant is only possible because of your generosity.

      Whilst the TSANZ 50th Anniversary Benevolent Grant does not target research, this is an exciting grant which we have had the privilege in sharing with you. Please find more information on this grant below. We have partnered with Thinkable.org and you are invited to visit this platform and see our grant online.

      We also have the good fortune of announcing the TSANZ / AstraZeneca Respiratory Research Fellowship is back and open for applications. This award will support one early-career researcher and one mid-career researcher with $60 000 each for one year. The research fellowship must be in asthma and/or COPD. More information can be found online.

      Please be reminded, the Thoracic Society Awards for Research and Career Development are open until the 13th of November. We also have more awards opening soon, so please keep in touch as the year draws to an end.

      Enjoy the November edition of your research roundup. 

      Prof Phil Hansbro

      Prof Sandra Hodge

      Co-Chairs, Research Sub-Committee

      TSANZ 50th Anniversary Benevolent Grant

      The Thoracic Society of Australia and New Zealand Ltd (TSANZ) Ltd became a Health Promotion Charity in 2011. With this, the 50th Anniversary TSANZ Benevolent Grant was established to help TSANZ contribute to worthwhile causes intended to improve respiratory health care delivery within Australia and New Zealand, and internationally. There is opportunity to raise funds for such special projects by receiving donations from TSANZ members. 

      Thanks to the generosity of TSANZ donors, the organisation is now able to make available two award categories to support philanthropic activities aimed at improving respiratory health care. This is not a research program. Funding must be used for philanthropic activities to improve respiratory health care in settings where resources and delivery are poor. For example, the purchase of equipment, the implementation of training for health care professionals or patients, or direct patient programs would qualify for this funding.

      Visit the TSANZ 50th Anniversary Benevolent Grant online!

      There are two award categories:

      • People’s Choice Award valued at up to $10,000 AUD
      • Directors Choice Award valued at up to $10,000 AUD

      There is up to $10,000 funding available for each category which may be provided to one or multiple awards. TSANZ reserves the right to not issue any funding. 

      Winners will be announced at the TSANZSRS ASM in Adelaide, 2018.

      Open Awards

      Thoracic Society Awards

      TSANZ Research and Career Development Awards

      TSANZ / AstraZeneca Respiratory Research Fellowship

      Closing soon: Midnight Monday 13 November 17

      TSANZ Peter Phelan Research Award

      TSANZ / National Asthma Council Australia – Asthma and Airways Fellowship

      Boeringher Ingelheim COPD Research Award

      Maurice Blackburn Grant-in-Aid for Occupational Lung Disease

      TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health

      TSANZ/LFA CSL Behring Research Award for Alpha-1 anti-trypsin deficiency 

      Deadline extended until allocation exhausted: TEVA Scholar Award for APSR

      Closing 21 January 18: TSANZ Indigenous Respiratory Nursing Award

      For more information visit https://www.thoracic.org.au/researchawards/tsanz-awards

      More coming soon!

       

      Lung Foundation Australia Awards

      Lung Foundation Australia / Cochrane Airways Australia Scholarship 2018

      Closing soon: 13 November 17

      Lung Foundation Australia and Cochrane Airways Australia invite applications for the Lung Foundation Australia/Cochrane Airways Australia Scholarship 2018 valued at $2,500. This scholarship is intended to assist with the completion, update and/or presentation of a Systematic Review. Cochrane Review Scholarships have been awarded on an annual basis since 2001, and have been highly productive.

      A Cochrane review is an ideal topic for an advanced trainee in any health profession, or when initiating a PhD program, as most reviews can be completed within a year. Completed reviews are published on the Cochrane Database of Systematic Reviews (Impact Factor 6.124 effective July 2016) and indexed in Medline. Conducting a review provides experience in critical appraisal of the literature, and other aspects of Evidence-Based Medicine.

      MORE INFORMATION

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      Watch this space for more award announcements…

       

      Respirology

      Editor’s Choice – Respirology Issue 22.8

      Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacity

      Yuki Sato, Daichi Fujimoto, Takeshi Morimoto, Keiichiro Uehara, Kazuma Nagata,Ichiro Sakanoue, Hiroshi Hamakawa, Yutaka Takahashi, Yukihiro Imai and Keisuke Tomii

      DOI: 10.1111/resp.13089

       

      The Research team at the Kobe City Medical Center General Hospital in Kobe, one of two research sites in Japan where this study was performed. 

       

       

      Dynamic loop gain increases upon adopting the supine body position during sleep in patients with obstructive sleep apnoea

      Simon A. Joosten, Shane A. Landry, Scott A. Sands, Philip I. TerrilL, Dwayne Mann, Christopher Andara, Elizabeth Skuza, Anthony Turton, Philip Berger, Garun S. Hamilton and Bradley A. Edwards

      DOI: 10.1111/resp.13108

       

      Melbourne (Australia)-based research team members from left to right: Christopher Andara, Shane Landry, Anthony Turton, Bradley Edwards, Simon Joosten and Garun Hamilton. Absent are Philip Berger, Scott Sands, Elizabeth Skuza, Philip Terrill and Dwayne Mann.

      New NHMRC grant program public consultation on peer review

      NHMRC invites submissions to its consultation paper on peer review in the new grant program. Submissions close 5:00pm (AEDT) on Monday 4 December 2017.

      To complement the consultation paper, NHMRC is hosting a series of public forums across Australia between 29 September and 24 November 2017 on elements of peer review. Registrations are currently being accepted.

      TSANZ will submit a response to this consultation on behalf of the society and you are encouraged to send in your opinion to the office to ensure our response is representative of our membership. Please tell us your opinion on the NHMRC peer review paper by the 17th of November by responding to hayley.see@thoracic.org.au

      Grant Bulletin

      This grant bulletin contains direct-to-researcher grants and awards due in 2017:

      Integra Underground Community Investment – closes 01/12/17
      Funding is provided for the following focus areas: Capacity Building, including education/training, enterprise development, and economic diversification; Health; Environment.

      Pro Bono Australia – Impact 25 Awards (2017) – closes 01/12/17
      Award to name the year’s most influential people who have made a significant and positive impact. Nominees should embody the principles of integrity, initiative, foresight, and collaboration.

      Auswide Community Grants Scheme –  closes 01/12/17.
      Supports local activities, organisations, events and projects covering a wide range of sporting, cultural and community interests and endeavours. Includes community services, events and celebrations, buildings, public spaces and facilities, research, and organisational development.

      Australian Respiratory Council Harry Windsor Research Grants Scheme – closes 07/12/17
      For projects which address research in tuberculosis, respiratory diseases due to other infections, or respiratory diseases related to tobacco use. Within these categories, projects examining TB/HIV, community issues or the health of disadvantaged groups that relate to the work that the ARC undertakes within Australia and the Pacific Region are particularly encouraged. The proposals can encompass clinical research, public health research or basic scientific research. Grants are available for projects submitted to the National Health and Medical Research Council (NHMRC) which are considered fundable but which do not reach the cut-off mark for funding in any one year.

      Perpetual Trustees 2018 IMPACT Philanthropy Application Program – closes 08/12/17
      Perpetual distributes to all sectors including social welfare, health, medical research, conservation and environment, education, and arts and culture. As is consistent with Perpetual’s IMPACT Philanthropy Application Program process, an organisation’s submission will be assessed against Leadership, Capability, Strategy and Outcomes. Further 2018 information will be released later in 2017.

      Allen Foundation Grants (2018) – closes 31/12/17
      Priorities are: to fund relevant nutritional research; to support programs for the education and training of mothers during pregnancy and after the birth of their children; to assist in the training of persons to work as educators and demonstrators of good nutritional practices; to encourage the dissemination of information regarding healthful nutritional practices and habits; in limited situations to make grants to help solve immediate emergency hunger and malnutrition problems.

      Rolling Grants

      John Templeton Foundation
      Interest areas are: science and the big questions; character virtue development; freedom and free enterprise; exceptional cognitive talent and genius; genetics; voluntary family planning.

      Boehringer Ingelheim Fonds Travel Grants
      Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

      Baxalta Bioscience Grants – Medical Education & Fellowship Grants
      Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

      The Balnaves Foundation
      The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

      Vertex Cystic Fibrosis Circle of Care Grants

      The CF Circle of Care program is a competitive grant initiative to fund innovative patient-centric programs within the CF community. Since launching the program in 2015, we have awarded 50 grants globally, with projects covering a wide variety of topics including transition, psycho-social care, and caregiver support. 

      Every fall, ahead of NACFC, awardees are invited to share their work at the CF Circle of Care colloquium, an inspiring event which serves as a forum to exchange ideas and meet others within the CF community.

      The program encourages both individual and collaborative efforts with grant awards of up to $100,000. This year, we will be extending the deadline to submit proposals in order to allow for more time to generate and discuss ideas within your community. The deadline to submit is midnight AEDT 30 November 2017.

      Further details of the program, eligibility criteria, and application process can be found on the Vertex grants website. In need of some inspiration? Check out the 2016 posters from the 2nd annual colloquium here.

      Personal Special Request

      Dear TSANZ Members,

      We are currently conducting a survey of  Australian clinicians involved in the care of patients with severe asthma, and are seeking your opinions on the Utility of Biomarkers for the Management of Corticosteroid Treatment. This is the first round of a Delphi process to reach a consensus and there will be follow-up questions based on the answers we receive from round one.

      Professor Peter Wark and I at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted in conjunction with this project, and understanding the current sentiment on the use of biomarkers in this patient population is crucial to furthering the future development and implementation of biomarkers, and the treatable trait approach in general. In addition, this is being done as a larger international effort to gauge opinions on the use of biomarkers across Europe and Australia.

      If you are currently involved in the management of patients with severe asthma, we would sincerely appreciate if you could take the time to complete the survey (link below) that has been sent out as part of the Asthma SIG this week.

      http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=l6M2m5m3

      Thank you,

      Professor Jodie Simpson

       

      Research Project and Survey Requests

      ‘Usual’ antenatal asthma management

      Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma managementconsists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

      If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

      Ethics approval has been granted for this study (NSW HREC Reference No: HREC/16/HNE/394).  All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

      Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser:

      https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

      Thank you,

      Dr Vanessa Murphy, Vanessa.Murphy@newcastle.edu.au
      Ms Karen McLaughlin, Karen.McLaughlin@hnehealth.nsw.gov.au

       

      Case Management of Venous thromboembolism

      Many thanks for your time in completing this short survey, which should take no longer than 5 minutes. At St. John of God, we are exploring the management of VTE in patients with or without malignancy and in the perioperative setting.

      We appreciate there are a large number of guidelines, many of which can be contradictory in their recommendation. Irrespective of this, we would greatly value your feedback on how you would manage the following cases, recognising that several answers may be appropriate.

      This survey consists of 4 short cases which will cover a range of clinical scenarios with regards the management of VTE in the immediate post-operative and preoperative period, as well as the management of VTE in the setting of suspected and confirmed solid organ malignancy.

      https://www.surveymonkey.com/r/IVCFilter

      All results are completely anonymised and your participation is greatly appreciated.

      Kind regards,

      Prof Eli Gabbay egabbay@respiratorywest.com.au
      Dr Philip Craven

      Australian Society for Medical Research National Scientific Conference

      Held in Sydney, at the Charles Perkins Centre, from November 14th to 15th, 2017 the NSC has an exciting new design all packed up in a shorter format.

      In these highly competitive times, the NSC 2017 will fulfil an important yet unmet need for early to mid career health and medical researchers.

      Entitled “Science and Survival – equipping you with the tools to further your research career” the aims of the  conference are:

      • To empower and inspire our present and future scientific leaders.
      • To provide a springboard for early to mid-career researchers to showcase their research.
      • To promote scientific excellence, collaboration and transdisciplinary research.
      • To upskill in grantsmanship and understand the promotion process.
      How are we going to achieve this?

      We are very excited about the new format of NSC 2017 with both scientific presentations and visionary professional development workshops.

      Conference highlights

      Mock GRP session with all the elements of a GRP and the perspective of a narrator.

      Inside the scientist studio – Norman Swan  interviews Nobel Prize Winner Professor Peter Doherty.

      Politics of promotion to provide invaluable insights into the intricate and necessary journey to Associate Professorship.

      The Edwards Orator is Distinguished Professor Jagadish Chennupati from ANU. A stellar transdisciplinary researcher and a nanotechnology pioneer. ­­­He is also a charismatic leader and mentor who will inspire our participants.

      Dr Bon-Kyoung Koo from the University of Cambridge will deliver the Firkin Oration. Dr Koo is an ascending star in stem cell research and a world leading researcher in the experimental dissection of human stomach development –  all generated from stem cells.

      ASMR Peter Doherty Leading Lights Award.  This year ASMR will launch a new award aimed at recognising the outstanding contributions of Australian mid-career researchers.

      The Networking and Mentoring Breakfast.  A unique opportunity for students in particular to share their concerns and ask questions of experienced mentors.

       

       

       

       
       
       
       
       
       
       
       
       

      .

      VOLUME 7.06 – JULY 2022

      VOLUME 2.8 OCTOBER 2017

      Research Roundup:

      October  2017

      .
       

      Welcome Message

      Please be reminded, the Thoracic Society Awards for Research and Career Development are open until the 13th of November. Some awards are new and some are different to previous years. We would like to encourage you to have a look below at the Open Awards and see which ones may help you in your research endeavours.

      We would also like to draw your attention to the NHMRC Peer Review Consultation which is now open on the NHMRC Public Consultations Portal. The consultation paper is available here. TSANZ will submit a response to this consultation on behalf of the society and you are encouraged to send in your opinion to the office to ensure our response is representative of our membership. Please let us know your opinion on the NHMRC peer review paper by the 17th of November by responding to hayley.see@thoracic.org.au

      Enjoy the October edition of your research roundup. This edition is focused on awards so please delve into the opportunities below as they span many area of research and different career stages.

      Prof Phil Hansbro

      Prof Sandra Hodge

      Co-Chairs, Research Sub-Committee

      Open Awards

      Thoracic Society Awards

      TSANZ Research and Career Development Awards now open

      TSANZ Peter Phelan Research Award

      TSANZ Indigenous Respiratory Nursing Award

      TSANZ / National Asthma Council Australia – Asthma and Airways Fellowship

      Boeringher Ingelheim COPD Research Award

      Maurice Blackburn Grant-in-Aid for Occupational Lung Disease

      TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health

      TSANZ/LFA CSL Behring Research Award for Alpha-1 anti-trypsin deficiency 

      TEVA Scholar Award for APSR

      Awards close 13 November 2017

      For more information visit https://www.thoracic.org.au/researchawards/tsanz-awards

      More coming soon!

       

      Lung Foundation Australia Awards

      Lung Foundation Australia / Cochrane Airways Australia Scholarship 2018

      Lung Foundation Australia and Cochrane Airways Australia invite applications for the Lung Foundation Australia/Cochrane Airways Australia Scholarship 2018 valued at $2,500. This scholarship is intended to assist with the completion, update and/or presentation of a Systematic Review. Cochrane Review Scholarships have been awarded on an annual basis since 2001, and have been highly productive.

      A Cochrane review is an ideal topic for an advanced trainee in any health profession, or when initiating a PhD program, as most reviews can be completed within a year. Completed reviews are published on the Cochrane Database of Systematic Reviews (Impact Factor 6.124 effective July 2016) and indexed in Medline. Conducting a review provides experience in critical appraisal of the literature, and other aspects of Evidence-Based Medicine.

      MORE INFORMATION

      Re-launched: Lung Foundation Australia and the Better Breathing Foundation Allied Health PhD Scholarship in Chronic Lung Disease – 2018/2021

      Valued at $20,000 per year for four years for a full-time student (total funding $80,000) or $10,000 per year for four years for a part-tome student (total funding $40,000). Co-funding from a University is optional but desirable.

      Deadline 6 November 2017

      Partnership form | Application form

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      Watch this space for more award announcements…

      TSANZ Awards by Nomination

      Deadline midnight AEDT Sunday 29 October

      The Society Medal

      The Society Medal was conceived as an acknowledgment of excellence in fields other than research, i.e. for the advancement of the practice of thoracic medicine in its widest sense by outstanding teaching or advocacy.

      The Research Medal

      The Research Medal is awarded in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in their field of research.

      The 50th Anniversary Medal for Education & Training

      The 50th Anniversary Medal for Education & Training was introduced in 2011 to mark the Society’s 50th Anniversary. The 50th Anniversary Medal is awarded in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in education and training.

      This might take the form of formal and informal teaching within a university, hospital or other health care setting; curriculum development at an undergraduate or postgraduate level; using research to enhance the efficacy of educational activities; career mentoring of junior members of the Society; integration of teaching into clinical practice; or advocacy on behalf of medical education as applied to respiratory medicine.

       

      New NHMRC grant program public consultation on peer review

      NHMRC invites submissions to its consultation paper on peer review in the new grant program. Submissions close 5:00pm (AEDT) on Monday 4 December 2017.

      To complement the consultation paper, NHMRC is hosting a series of public forums across Australia between 29 September and 24 November 2017 on elements of peer review. Registrations are currently being accepted.

      TSANZ will submit a response to this consultation on behalf of the society and you are encouraged to send in your opinion to the office to ensure our response is representative of our membership. Please let us know your opinion on the NHMRC peer review paper by the 17th of November by responding to hayley.see@thoracic.org.au

      Grant Bulletin

      This grant bulletin contains direct-to-researcher grants and awards due in 2017:

      Bill & Melinda Gates Foundation Grand Challenges Explorations Round 20 – closes 08/11/17
      Early-stage innovative research projects from a range of disciplines and regions. The challenges for Round 20 are: Healthy Minds for Adolescent Mothers: Achieving Healthy Outcomes for the Family; Innovations for Integrated Diagnostics Systems; Novel Approaches for Improving Timeliness of Routine Immunisation Birthdose and Healthcare Worker Skill in Low-Resource Settings.

      Integra Underground Community Investment – closes 01/12/17
      Funding is provided for the following focus areas: Capacity Building, including education/training, enterprise development, and economic diversification; Health; Environment.

      Pro Bono Australia – Impact 25 Awards (2017) – closes 01/12/17
      Award to name the year’s most influential people who have made a significant and positive impact. Nominees should embody the principles of integrity, initiative, foresight, and collaboration.

      Auswide Community Grants Scheme –  closes 01/12/17.
      Supports local activities, organisations, events and projects covering a wide range of sporting, cultural and community interests and endeavours. Includes community services, events and celebrations, buildings, public spaces and facilities, research, and organisational development.

      Australian Respiratory Council Harry Windsor Research Grants Scheme – closes 07/12/17
      For projects which address research in tuberculosis, respiratory diseases due to other infections, or respiratory diseases related to tobacco use. Within these categories, projects examining TB/HIV, community issues or the health of disadvantaged groups that relate to the work that the ARC undertakes within Australia and the Pacific Region are particularly encouraged. The proposals can encompass clinical research, public health research or basic scientific research. Grants are available for projects submitted to the National Health and Medical Research Council (NHMRC) which are considered fundable but which do not reach the cut-off mark for funding in any one year.

      Perpetual Trustees 2018 IMPACT Philanthropy Application Program – closes 08/12/17
      Perpetual distributes to all sectors including social welfare, health, medical research, conservation and environment, education, and arts and culture. As is consistent with Perpetual’s IMPACT Philanthropy Application Program process, an organisation’s submission will be assessed against Leadership, Capability, Strategy and Outcomes. Further 2018 information will be released later in 2017.

      Allen Foundation Grants (2018) – closes 31/12/17
      Priorities are: to fund relevant nutritional research; to support programs for the education and training of mothers during pregnancy and after the birth of their children; to assist in the training of persons to work as educators and demonstrators of good nutritional practices; to encourage the dissemination of information regarding healthful nutritional practices and habits; in limited situations to make grants to help solve immediate emergency hunger and malnutrition problems.

      Rolling Grants

      John Templeton Foundation
      Interest areas are: science and the big questions; character virtue development; freedom and free enterprise; exceptional cognitive talent and genius; genetics; voluntary family planning.

      Boehringer Ingelheim Fonds Travel Grants
      Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

      Baxalta Bioscience Grants – Medical Education & Fellowship Grants
      Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

      The Balnaves Foundation
      The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

      Research Project and Survey Requests

      Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

      If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

      We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma. This is the first round of a multi-national Delphi process to reach a consensus and there will be follow-up questions based on the answers we receive from round one (with likely three rounds in total).

      A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Research Masters degree by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

      For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

      If you agree to participate, please follow the link to complete the survey

      http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=l6M2m5m3

      Thank you,

      Peter Wark
      Jodie Simpson
      J. Michael Ramsahai 
      JamesMichael.Ramsahai@uon.edu.au

       

      Case Management of Venous thromboembolism

      Many thanks for your time in completing this short survey, which should take no longer than 5 minutes. At St. John of God, we are exploring the management of VTE in patients with or without malignancy and in the perioperative setting.

      We appreciate there are a large number of guidelines, many of which can be contradictory in their recommendation. Irrespective of this, we would greatly value your feedback on how you would manage the following cases, recognising that several answers may be appropriate.

      This survey consists of 4 short cases which will cover a range of clinical scenarios with regards the management of VTE in the immediate post-operative and preoperative period, as well as the management of VTE in the setting of suspected and confirmed solid organ malignancy.

      https://www.surveymonkey.com/r/IVCFilter

      All results are completely anonymised and your participation is greatly appreciated.

      Kind regards,

      Prof Eli Gabbay egabbay@respiratorywest.com.au
      Dr Philip Craven

      Australian Society for Medical Research National Scientific Conference

      Held in Sydney, at the Charles Perkins Centre, from November 14th to 15th, 2017 the NSC has an exciting new design all packed up in a shorter format.

      In these highly competitive times, the NSC 2017 will fulfil an important yet unmet need for early to mid career health and medical researchers.

      Entitled “Science and Survival – equipping you with the tools to further your research career” the aims of the  conference are:

      • To empower and inspire our present and future scientific leaders.
      • To provide a springboard for early to mid-career researchers to showcase their research.
      • To promote scientific excellence, collaboration and transdisciplinary research.
      • To upskill in grantsmanship and understand the promotion process.
      How are we going to achieve this?

      We are very excited about the new format of NSC 2017 with both scientific presentations and visionary professional development workshops.

      Conference highlights

      Mock GRP session with all the elements of a GRP and the perspective of a narrator.

      Inside the scientist studio – Norman Swan  interviews Nobel Prize Winner Professor Peter Doherty.

      Politics of promotion to provide invaluable insights into the intricate and necessary journey to Associate Professorship.

      The Edwards Orator is Distinguished Professor Jagadish Chennupati from ANU. A stellar transdisciplinary researcher and a nanotechnology pioneer. ­­­He is also a charismatic leader and mentor who will inspire our participants.

      Dr Bon-Kyoung Koo from the University of Cambridge will deliver the Firkin Oration. Dr Koo is an ascending star in stem cell research and a world leading researcher in the experimental dissection of human stomach development –  all generated from stem cells.

      ASMR Peter Doherty Leading Lights Award.  This year ASMR will launch a new award aimed at recognising the outstanding contributions of Australian mid-career researchers.

      The Networking and Mentoring Breakfast.  A unique opportunity for students in particular to share their concerns and ask questions of experienced mentors.

       

       

       

       

       
       
       
       
       
       
       
       
       

      .

      VOLUME 7.06 – JULY 2022

      VOLUME 1.03 MAY 2016

      Research Roundup:

      May 2016

      .
       

      Welcome Message

      Welcome to the third edition of the TSANZ Research Round Up. 

      The ASM for 2016 has now passed and I trust everyone enjoyed the event. If you would like to relive some research moments, the 2016 Award Winners photos have been uploaded on the TSANZ website. There are many awards listed on that page and I would like to thank the Research SubCommittee and the invited reviewers for their hard work in reviewing every one of these.

      The ASM was a cracking event where we told each other, Australia, New Zealand, and the many international attendees, about what we are up to in Respiratory Medicine. Media coverage of this year’s TSANZ ASM broke all records, taking news of the conference, new research, and TSANZ as the lead body representing lung health experts, to millions of Australians nationwide. Particular emphasis was placed on conveying key messages regarding Coal Workers Pneumoconiosis, the importance of lung health research, the crisis in funding and the unveiling of Lungs for Life. It was great to see the TSANZ profile continue to build and you can review all the media coverage which TSANZ has recently received as part of the new Advocacy section of the TSANZ website.

      We are also trialling keeping up with what our members are up to in the media. So if YOU are in the news because of your work in respiratory medicine, please let us know by dropping a line to Hayley.See@thoracic.org.au

      Please remember to check out the surveys below and continue to support each other’s research.

      Enjoy your May Research Roundup,

      Prof Phil Hansbro

      Chair, Research Sub-Committee

      TSANZ Congratulates 2016 Award Winners

       

      Fellowships

      TSANZ / AstraZeneca Respiratory Research Fellowship

      Presented to Dr Alan Hsu, University of Newcastle, Hunter Medical Research Institute

      TSANZ / National Asthma Council Australia – Asthma and Airways Career Development Fellowship

      Presented to Dr Miranda Ween, Royal Adelaide Hospital, University of Adelaide

      TSANZ/Vertex Paediatric Cystic Fibrosis Clinical Fellowship

      Presented to Dr Bernadette Prentice, Sydney Children’s Hospital, NSW

      Special Awards

      Society Medal presented to Professor Iven Young

      50th Anniversary Medal presented to Professor Peter Frith

      President’s Award presented to Professor Billie Bonevski

      Research Medal presented to Professor Ron Grunstein

      Wunderly Oration was delivered by Professor Patrick Holt

      Abstract-linked Awards

      Ann Woolcock Young Investigator Finalists

      Dr Hashim Periyalil, University of Newcastle/Hunter Medical Research Institute
      Dr Kristin Carson, The University of Adelaide/The Queen Elizabeth Hospital [Winner]
      Ms Francesca Tang, Woolcock Institute Of Medical Research
      Dr Richard Kim, University of Newcastle/Hunter Medical Research Institute
      Ms Louise Organ, University of Melbourne
      Ms Bernadette Jones, University of Newcastle/Hunter Medical Research Institute

      TSANZ Janet Elder Early Career Travel Awards

      Dr Chantal Donovan, University of Newcastle, Hunter Medical Research Institute
      Dr Richard Kim, University of Newcastle, Hunter Medical Research Institute

      TSANZ / Japanese Respiratory Society Early Career Travel Award

      Dr Megan Jensen, University of Newcastle, Hunter Medical Research Institute

      TSANZ / Boehringer Ingelheim COPD Travel Award

      Dr Stephen Milne, Woolcock Institute of Medical Research, NSW

      TSANZ / Slater & Gordon Mesothelioma International Travel Award

      Prof YC Gary Lee, Sir Charles Gairdner Hospital, Perth

      Grants-In-Aid

      TSANZ / AstraZeneca Severe Asthma GIA

      Dr Richard Kim, University of Newcastle, Hunter Medical Research Institute

      TSANZ / Maurice Blackburn GIA

      Dr Rajesh Thomas, Sir Charles Gairdner Hospital, Perth

      TSANZ Robert Pierce GIA for Indigenous Lung Health

      Prof Sandra Hodge, Hanson Institute and Thoracic Medicine, Royal Adelaide Hospital

      Travel Awards

      TSANZ Peter Phelan Travel Fellowship

      Dr Megan Jensen, University of Newcastle/Hunter Medical Research Institute

      TSANZ / Vertex Cystic Fibrosis Research Award

      Dr. Rachel Foong, Telethon Kids Institute, WA

      Ms Michelle Wood, The Prince Charles Hospital, QLD

      TSANZ Indigenous Respiratory Nurses Award

      Mrs Kerry Hall, Queensland University of Technology, Centre for Children’s Health Research

      Asthma Australia

      Travel Awards for Mid-Career Researchers

      Dr Jay Horvat, University of Newcastle/Hunter Medical Research Institute

      A/Prof Vanessa McDonald, University of Newcastle/Hunter Medical Research Institute

      Dr Hai Tran, Hanson Institute and Thoracic Medicine/Royal Adelaide Hospital

      Best Poster of the ASM Award

      TSANZ Best Poster Prize (supported by Boehringer Ingelheim) – presented to Mr Jesse Armitage
      Abstract: “Mesenchymal stem cell infusion modulates systemic inflammation in patients with chronic obstructive pulmonary disease (COPD)”

      Special Interest Group Awards

      Asthma & Allergy (supported by National Asthma Council Australia) – presented to Ms Esther Cheah

      Asthma & Allergy (supported by Asthma Australia) – presented to Dr Megan Jensen

      Pulmonary Physiology and Sleep, John Reid Prize (supported by Lung Foundation Australia) – presented to Ms Kanika Jetmalani

      David Serisier Memorial Award 2016 for Translational Research in Respiratory Infectious Disease (supported by Lung Foundation Australia) – presented to Dr Gregory Fox

      OELD/Population Health (supported by Maurice Blackburn ) – presented to Dr Isuru Seneviratne

      Lung Cancer (supported by Maurice Blackburn) – presented to Dr Sally Lansley

      OLIV (supported by Boehringer Ingelheim) – presented to Mr Kenneth Sinclair

      Primary Care (supported by Boehringer Ingelheim) – presented to A/Prof Lorraine Smith

      Respiratory Nurses Oral (supported by Boehringer Ingelheim) – presented to Mrs Kerry Hall

      Cell biology/Immunology – Mr Thomas Iosifidis

      COPD – presented to Mrs Netsanet Negewo

      Cystic Fibrosis – presented to Dr Daan Caudri

      Evidence Based Medicine – presented to Ms Zoe Kopsaftis

      Interventional Pulmonology – presented to Dr David Fielding

      Physiotherapy – presented to Mr Jamie Wood

      Tobacco Control – presented to A/Prof Alexander Larcombe

      Peter van Asperen Paediatric Award – presented to Dr Elizabeth Kepreotes

      Lung Foundation Awards

      Lung Foundation Australia / Boehringer Ingelheim COPD Fellowship 2016/2017

      Dr Christian Osadnik, Monash University, Monash Health

      Lung Foundation Australia Ivan Cash Research Grant-in-Aid Award

      Dr Helen Jo, Royal Prince Alfred Hospital

      Lung Foundation Australia Lizotte Family Research Award

      Mr Gang Liu,University of Newcastle, Hunter Medical Research Institute

      Lung Foundation Australia Ludwig Engel Grant-in-Aid for Physiological Research

      A/Prof Sandra Orgeig, A/Prof. Alex Larcombe and Dr Emma Parkinson-Lawrence, University of South Australia/Telethon Kids Institute, WA

      Lung Foundation Australia / Australian Cochrane Airways Group Scholarship

      Ms Anke Lenferink, Flinders University, Repatriation General Hospital, Adelaide

      Cochrane Airways Australian Satellite

      Ms Harshani Jayasinghe, The University of Adelaide, The Queen Elizabeth Hospital

      The following articles will take you to www.thelimbic.com

      the limbic is a free, independent news site for respiratory health professionals that covers the latest in clinical research and medico-political news.

      ‘Futile’ treatment causes confusion. The debate over how to define ‘futile’ treatment has hit the headlines again, with a new study showing doctors support the concept but more than half have difficulty coming to a consensus on how to approach it in a clinical setting. Read More. 

      Gene therapy for PAH. In this month’s holy grail we caught up with recipient of the 2015 TSANZ Ann Woolcock Young Investigator Award Rebecca Harper on her work with endothelial progenitor cells to find a better treatment, and potentially a cure, for patients living with pulmonary arterial hypertension. Read More.

      Specialised clinics needed in advanced COPD. Patients with advanced lung disease need specialised care to help address issues such as end-of-life care planning, says a respiratory physician who has set up an innovative clinic in Melbourne. Read More.

      Inhalers have become a ‘fashion accessory’. This is just one quote from an editorial penned by the UK’s respiratory dynamic duo Professor Andrew Bush and Dr Louise Fleming on the over diagnosis of asthma in children. We spoke to Professor Adam Jaffe to get an Australian perspective. Read More.

      Promising on paper but…  The release of a Cochrane review showing high dose oral NSAIDs can slow the progression of lung damage in people with cystic fibrosis is unlikely to change clinical practice, says a leading Australian respiratory physician and researcher. Read More.

      When Pseudomonas aeruginosa cells explode. Microbiologists have made a breakthrough in understanding how the superbug Pseudomonas aeruginosa causes infection. Read More.

      Name that lung sound. An international task force has reached a consensus on the naming of lung sounds – in 29 languages. Are ‘crackle’ and ‘wheeze’ still approved terms? Read More.

       

      If you have any issues accessing the limbic please contact editor@thelimbic.com

      Research Project and Survey Requests

      International Malignant Pleural Effusion Practice Survey

      In 2003, an international survey was conducted to gain an idea on the variations in pleurodesis practices for malignant pleural effusions in different parts of the world. The study provided useful data and highlighted areas of significant differences in practice that could be addressed with clinical trials.  In the last 12 years, malignant pleural disease management has dramatically changed especially with the increasing use of indwelling pleural catheters and medical thoracoscopy.  Given the options available researchers would like to see how opinions and practice vary across the world. (Lee, Rahman, Ahmed, Feller-Kopman, Sivakumar). 

      They would be most grateful if colleagues could find the time to complete the following survey which will take approximately 15 minutes to complete.

      To ensure that all information will remain confidential and anonymous, researchers will not record any personal information including IP addresses. You have the option of providing your email address if you would like to receive a copy of the analysed results. Email addresses will be recorded on a separate database to keep responses anonymous. Your email address will not be used for any other reason or correspondence.

      The survey can be found at http://www.tinyurl.com/pleuralsurvey
      Thank you!

      Austrailan Co-ordinator: Prof YC Gary Lee 

       

      The Breathing for Life Trial (BLT)

      BLT is a randomised trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health.

      We are seeking volunteers with doctor diagnosed asthma, asthma symptoms or medication use in previous 12 months, 18 years of age or older, 12-22 weeks gestation, smokers and non-smokers.

      This trial will take place at;

      – John Hunter Hospital, Newcastle NSW
      – Royal Hospital for Women, Randwick NSW
      – Nepean Hospital, NSW
      – Royal Brisbane and Women’s Hospital, QLD
      – Royal North Shore Hospital, NSW
      – Canberra Hospital, ACT

      Click here to read more about this trial
      Participant Information Statement and Consent Form [PDF]

      For more information please contact Dr Megan Jensen: Ph (02) 4042 0130 | breathingforlifetrial@gmail.com | Facebook

      Pleural and Lung Ultrasound Survey (For Physicians & Advanced Trainees)

      You are invited to participate in this voluntary survey that aims to describe current pleural and lung ultrasound training practices in Australia and New Zealand amongst respiratory physicians and advanced trainees to help improve this training. The data will then be compared to a similar survey conducted in 2011 to determine whether progress is being made in the area of pleural ultrasound training.

      We know that your time is valuable and therefore the survey has been kept short and will take only a few minutes to complete (14 MCQs, 5 minutes). All responses will be anonymous and analysed as a cohort. Your assistance will help shape future training provision within the Society.

      Survey Link: https://www.surveymonkey.com/r/PleuralUS

      Please find contact details below if you would like more information about this study.

      Dr Eve Denton, Respiratory and Sleep Medicine Advanced Trainee, Alfred Hospital, Melbourne
      Dr Mark Hew , Head of Allergy Department, Alfred Hospital, Melbourne

      Venous Thrombo-Embolism Survey

      Dear Colleague,

      Our research team is conducting a brief survey to better understand how physicians currently approach the management of patients with suspected and proven venous thromboembolism. We are currently inviting physicians who manage patients with venous thromboembolism throughout Australia to take part. The results of the survey will provide valuable information to guideline developers and may help in the development of educational resources for physicians and trainees who manage this group of patients.

      We invite you to take part in a voluntary online survey, which will take approximately 10 minutes to complete.  There are no right or wrong answers to the questions in this survey.

      Ethics approval has been granted for this study by Melbourne Health (Approval number QA2015182) and there are no anticipated risks to you by taking part in this research. All survey responses will be anonymous and confidential. No personal information that could identify you is being collected and your email address will not be linked to your survey response. Your consent to participate in this study is implied by completing the survey.

      If you have any questions regarding this research, please do not hesitate to contact Dr Renee Manser or Mr Rory Wallace directly. Thank you in advance for participating.

      If you have any complaints about any aspect of the project, the way it is being conducted or any questions about your rights as a research participant, then you may contact Ms Jessica Turner, Manager Human Research Ethics Committees, Melbourne Health on (03) 9342 8530. You will need to tell Ms Turner the number or name of the project (see above).

      Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser. 

      Survey Link: https://www.surveymonkey.com/r/rmhvte

      Dr Renee Manser, Respiratory Physician, Department of Respiratory Medicine, The Royal Melbourne Hospital, Tel: 03 9342 7708
      Mr Rory Wallace, Medical Student, Department of Respiratory Medicine, The Royal Melbourne Hospital, Tel: 03 9342 7708
      A/Prof Louis Irving, Director of Respiratory & Sleep Medicine, The Royal Melbourne Hospital, Melbourne
      Dr Mary Ann Anderson, Haematologist, Department of Clinical Haematology and Bone Marrow Transplant Service, The Royal Melbourne Hospital

      Interview for physicians’ perspectives on the use of domiciliary oxygen therapy in interstitial lung disease (For Physicians) 

      Researchers at Austin Health are currently recruiting respiratory physicians for a qualitative study investigating their views with the use of domiciliary oxygen therapy in patients with interstitial lung disease.

      Invitation letter [PDF]

      Participant Information Statement and Consent Form [PDF]

      To take part in the study or receive further information, please contact Yet Hong Khor on 03 9496 5390

      Using drawings to further understanding of people’s perceptions and experiences of their asthma 

      You are invited to take part in a research study exploring the use of drawings to further understanding of people’s perceptions and experiences of their asthma.

      This study is being conducted by researchers from the University of Sydney. You will be asked to complete a survey, a spirometry reading, an interview and a drawing activity. This will be conducted in one sitting and in-person with a researcher. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

      You can take part in this study if you are over 18 years of age and have been told by your doctor that you have asthma.

      Invitation letter [PDF]

      Participant Information Statement [PDF]

      If you would like more details or would like to take part, please contact the researchers (details below):

      A/Prof Lorraine Smith, Associate Professor, Faculty of Pharmacy, the University of Sydney. Telephone: 02 9036 7079
      Ms Melissa Cheung, PhD Candidate, Faculty of Pharmacy, the University of Sydney.  Telephone: 02 9351 3710

       
       
       
       
       

       

       

       

       
       
       
       
       
       
       
       
       

      .

      VOLUME 7.06 – JULY 2022

      VOLUME 1.01 FEBRUARY 2016

      Research Roundup:

      February 2016

      .
       

      Welcome Message

      Welcome to the first edition of the TSANZ Research Roundup! This new communication is being delivered in collaboration with the limbic . This communication will be circulated monthly, and is our opportunity to request and share knowledge within the Society. The TSANZ Research Roundup will typically give you an update of TSANZ research activities, provide a quick list of open awards, showcase our researchers, and deliver the latest respiratory research to your inbox.

      You are all invited to send in your research requests and news to our Research Coordinator, including significant achievements, surveys, and study volunteer opportunities.

      This first edition comes as we prepare for the upcoming ASM in Perth (Please remember to register). The current Research Sub-Committee has reviewed over 100 award applications and looks forward to presenting over $500 000 of research funding to our members at the 2016 ASM. Members of the Research Sub-Committee come from a blend of research backgrounds, representing respiratory specialities in areas of basic, clinical, and translational research, or a combination of these. If you are interested in participating in this Subcommittee, I am happy to inform you that expressions of interests for these will remain open until the 25th of March. (Click here to Submit an EoI to join the Subcommittee)

      Enjoy your February Research Roundup,

       

      Prof Phil Hansbro

      Chair, Research Sub-Committee

      TSANZ Open Awards

      The following articles will take you to www.thelimbic.com

      the limbic is a free, independent news site for respiratory health professionals that covers the latest in clinical research and medico-political news.

      To access any of these articles simply click on one of the links below and create an account using your name and email. There are no hidden costs and your data will not be shared with anyone, ever.

      Asthma exacerbations in pregnancy. In this week’s Holy Grail we caught up with research scientist Dr Vanessa Murphy about her work investigating the characteristics, mechanisms and consequences of asthma exacerbations during pregnancy and their health impact on both the mother and baby. Dr. Vanessa Murphy was supported by the 2014 TSANZ-Asthma Australia Travel Award to present her research at the European Respiratory Congress in Munich, Germany. Read More.

      A spoonful of salt helps the medicine go down. Hypertonic saline is well tolerated, improves lung function and speeds the resolution of symptoms in people with cystic fibrosis who have been hospitalised with a pulmonary exacerbation, an Australian randomised trial finds. Read More.

      Label free approach needed. The current approach to defining a patient’s symptoms using the diagnostic labels of asthma and COPD is out dated and fails to provide optimal care in a significant number of patients, international and Australian experts claim. Read More.

      Pleurodesis findings challenge guidelines. It may no longer be necessary to avoid NSAIDs in patients with malignant pleural effusion undergoing pleurodesis a randomized trial shows. The findings also throw up questions around the optimal size of chest tubes to use during the procedure. Read More.

      Evidence grows for efficacy of endobronchial coils. Evidence is growing to support the use of endobronchial coils in patients with severe emphysema, with the release of one of the most significant studies to date. We spoke to Brisbane-based thoracic physician Dr David Fielding about the findings. Read More.

      E-cigarette review ‘grossly misleading’. Experts have poured scorn on a recent meta-analysis published in Lancet Respiratory Medicine that suggests those who use e-cigarettes are less likely to quit than smokers who don’t. Read More.

      If you have any issues accessing the limbic please contact editor@thelimbic.com

      Research Project and Survey Requests

       

      Pleural and Lung Ultrasound Survey (For Physicians & Advanced Trainees)

      You are invited to participate in this voluntary survey that aims to describe current pleural and lung ultrasound training practices in Australia and New Zealand amongst respiratory physicians and advanced trainees to help improve this training. These data will then be compared to a similar survey conducted in 2011 to determine whether progress is being made in the area of pleural ultrasound training.

      We know that your time is valuable and therefore the survey has been kept short and will take only a few minutes to complete (14 MCQs, 5 minutes). All responses will be anonymous and analysed as a cohort. Your assistance will help shape future training provision within the Society.

      Survey Link: https://www.surveymonkey.com/r/PleuralUS

      Please find contact details below if you would like more information about this study.

      Dr Eve Denton, Respiratory and Sleep Medicine Advanced Trainee, Alfred Hospital, Melbourne

      Email: eve.denton@gmail.com

      Dr Mark Hew, Head of Allergy Department, Alfred Hospital, Melbourne

      Email: M.Hew@alfred.org.au

       

      Interview for physicians’ perspectives on the use of domiciliary oxygen therapy in interstitial lung disease (For Physicians)

      Researchers at Austin Health are currently recruiting respiratory physicians for a qualitative study investigating their views with the use of domiciliary oxygen therapy in patients with interstitial lung disease.

      Click here to download the invitation letter [PDF]

      Click here to download Participant Information Statement and Consent Form [PDF]

      To take part in the study or receive further information, please contact Yet Hong Khor on 03 9496 5390 or YetHong.Khor@austin.org.au.

       

      Using drawings to further understanding of people’s perceptions and experiences of their asthma 

      You are invited to take part in a research study exploring the use of drawings to further understanding of people’s perceptions and experiences of their asthma.

      This study is being conducted by researchers from the University of Sydney. You will be asked to complete a survey, a spirometry reading, an interview and a drawing activity. This will be conducted in one sitting and in-person with a researcher. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

      You can take part in this study if you are over 18 years of age and have been told by your doctor that you have asthma.

      Click here to download the invitation letter [PDF]

      Click here to download Participant Information Statement [PDF]

      If you would like more details or would like to take part, please contact the researchers (details below):

      A/Prof Lorraine Smith, Associate Professor, Faculty of Pharmacy, the University of Sydney

      Email: lorraine.smith@sydney.edu.au    Telephone: 02 9036 7079

      Ms Melissa Cheung, PhD Candidate, Faculty of Pharmacy, the University of Sydney

      Email: mche7750@uni.sydney.edu.au    Telephone: 02 9351 3710

       

       

       
       
       
       
       
       
       
       
       

      .

      WHY JOIN US?

      Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

      By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

      X